Glycated hemoglobin as a marker of subclinical atherosclerosis and cardiac remodeling among non-diabetic adults from the general population

Diabetes Research and Clinical Practice

Volumn 105, Issue 3, 2014, Pages 416-423

  Haring, Robin ^a,b   Baumeister, Sebastian E ^a   Lieb, Wolfgang ^a,c   von Sarnowski, Bettina ^a   Völzke, Henry ^a,b   Felix, Stephan B ^a,b   Nauck, Matthias ^a,b   Wallaschofski, Henri ^a,b  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Atherosclerosis; Cardiac remodeling; Epidemiology; Glycated hemoglobin; Left ventricular mass

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ARTERY INTIMA PROLIFERATION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; GERMANY; HEART CONTRACTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SMOKING; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; COHORT ANALYSIS; COMMON CAROTID ARTERY; ECHOGRAPHY; HEART VENTRICLE FUNCTION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; POLAND; RISK; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; ODDS RATIO; POLAND; RISK; RISK FACTORS; VENTRICULAR DYSFUNCTION;

EID: 84921674156     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.05.004     Document Type: Article

References (56)

1. Forrest R.D., Jackson C.A., Gould B.J., Casburn-Budd M., Taylor J.E., Yudkin J.S. Four assay methods for glycated hemoglobin compared as screening tests for diabetes mellitus: the Islington Diabetes Survey. Clin Chem 1988, 34:145-148.
2. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
3. Saudek C.D., Herman W.H., Sacks D.B., Bergenstal R.M., Edelman D., Davidson M.B. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:2447-2453.
4. Selvin E., Marinopoulos S., Berkenblit G., Rami T., Brancati F.L., Powe N.R., et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004, 141:421-431.
5. Elley C.R., Kenealy T., Robinson E., Drury P.L. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabetes Med 2008, 25:1295-1301.
6. Singer D.E., Nathan D.M., Anderson K.M., Wilson P.W., Evans J.C. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992, 41:202-208.
7. Selvin E., Coresh J., Golden S.H., Brancati F.L., Folsom A.R., Steffes M.W. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 2005, 165:1910-1916.
8. Sarwar N., Aspelund T., Eiriksdottir G., Gobin R., Seshasai S.R., Forouhi N.G., et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med 2010, 7:e1000278.
9. Sarwar N., Gao P., Seshasai S.R., Gobin R., Kaptoge S., Di Angelantonio E., et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375:2215-2222.
10. Matsushita K., Blecker S., Pazin-Filho A., Bertoni A., Chang P.P., Coresh J., et al. The association of hemoglobin A1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes 2010, 59:2020-2026.
11. Muntner P., Wildman R.P., Reynolds K., Desalvo K.B., Chen J., Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care 2005, 28:1981-1987.
12. Selvin E., Steffes M.W., Zhu H., Matsushita K., Wagenknecht L., Pankow J., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New Engl J Med 2010, 362:800-811.
13. Barr E.L., Boyko E.J., Zimmet P.Z., Wolfe R., Tonkin A.M., Shaw J.E. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study. Diabetologia 2009, 52:415-424.
14. Khaw K.T., Wareham N., Luben R., Bingham S., Oakes S., Welch A., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ (Clin Res Ed) 2001, 322:15-18.
15. Gerstein H.C., Islam S., Anand S., Almahmeed W., Damasceno A., Dans A., et al. Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study. Diabetologia 2010.
16. McNeely M.J., McClelland R.L., Bild D.E., Jacobs D.R., Tracy R.P., Cushman M., et al. The association between A1C and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis. Diabetes Care 2009, 32:1727-1733.
17. Sander D., Schulze-Horn C., Bickel H., Gnahn H., Bartels E., Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke: J Cereb Circ 2006, 37:351-357.
18. Selvin E., Coresh J., Golden S.H., Boland L.L., Brancati F.L., Steffes M.W. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 2005, 28:1965-1973.
19. Marini M.A., Succurro E., Castaldo E., Cufone S., Arturi F., Sciacqua A., et al. Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria. Diabetes Care 2012, 35:1144-1149.
20. Bobbert T., Mai K., Fischer-Rosinsky A., Pfeiffer A.F., Spranger J. A1C is associated with intima-media thickness in individuals with normal glucose tolerance. Diabetes Care 2010, 33:203-204.
21. Preiss D., Sattar N. HbA1c: a useful cardiovascular risk marker in those without diabetes? 2010, Diabetologia.
22. Volzke H., Alte D., Schmidt C.O., Radke D., Lorbeer R., Friedrich N., et al. Cohort profile: the study of health in pomerania. Int J Epidemiol 2011, 40:294-30723.
23. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
24. Ludemann J., Piek M., Wood W.G., Meyer S., Greiner B., John U., et al. Methods for quality assurance of medical examination in epidemiological field studies: the Study of Health in Pomerania (SHIP). Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2000, 62:234-243.
25. Djaberi R., Schuijf J.D., Jukema J.W., Rabelink T.J., Stokkel M.P., Smit J.W., et al. Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetes. Diabetes Care 2010, 33:372-374.
26. Lester S.J., Eleid M.F., Khandheria B.K., Hurst R.T. Carotid intima-media thickness and coronary artery calcium score as indications of subclinical atherosclerosis. Mayo Clin Proc 2009, 84:229-233.
27. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
28. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
29. Fioretti P., Roelandt J., Bos R.J., Meltzer R.S., van Hoogenhuijze D., Serruys P.W., et al. Echocardiography in chronic aortic insufficiency. Is valve replacement too late when left ventricular end-systolic dimension reaches 55mm?. Circulation 1983, 67:216-221.
30. Cummings P. Methods for estimating adjusted risk ratios. Stata J 2009, 9:175-196.
31. Steyerberg E.W. Clinical prediction models 2009, Berlin, Springer.
32. Seaman S.R., White I.R. Review of inverse probability weighting for dealing with missing data 2012, Stat Meth Med Res.
33. Royston P., Sauerbrei W. Two techniques for investigating interactions between tratment and continous covariates in clinical trials. Stata J 2009, 9:230-251.
34. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
35. Pencina M.J., D'Agostino R.B., Demler O.V. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med 2012, 31:101-113.
36. Bennett C.M., Guo M., Dharmage S.C. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabetes Med 2007, 24:333-343.
37. American Diabetes Association Executive summary: standards of medical care in diabetes - 2012. Diabetes Care 2012, 35(Suppl. 2):S4-S10. PMID: 22187471.
38. Silbernagel G., Grammer T.B., Winkelmann B.R., Boehm B.O., Marz W. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography. Diabetes Care 2011, 34:1355-1361.
39. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004, 141:413-420.
40. Selvin E., Coresh J., Shahar E., Zhang L., Steffes M., Sharrett A.R. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 2005, 4:821-826.
41. Pradhan A.D., Rifai N., Buring J.E., Ridker P.M. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Ame J Med 2007, 120:720-727.
42. Blake G.J., Pradhan A.D., Manson J.E., Williams G.R., Buring J., Ridker P.M., et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 2004, 164:757-761.
43. Lawlor D.A., Fraser A., Ebrahim S., Smith G.D. Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med 2007, 4:e263.
44. de Vegt F., Dekker J.M., Ruhe H.G., Stehouwer C.D., Nijpels G., Bouter L.M., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 1999, 42:926-931.
45. Cederberg H., Saukkonen T., Laakso M., Jokelainen J., Harkonen P., Timonen M., et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010, 33:2077-2083.
46. Temelkova-Kurktschiev T.S., Koehler C., Henkel E., Leonhardt W., Fuecker K., Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000, 23:1830-1834.
47. Larsen J.R., Brekke M., Bergengen L., Sandvik L., Arnesen H., Hanssen K.F., et al. Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes. Diabetologia 2005, 48:776-779.
48. Hung C.S., Lee P.C., Li H.Y., Ma W.Y., Lin M.S., Wei J.N., et al. Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population. Clin Endocrinol (Oxf) 2011, 75:780-785.
49. Kim C.S., Park S.Y., Yu S.H., Kang J.G., Ryu O.H., Lee S.J., et al. Is A1C variability an independent predictor for the progression of atherosclerosis in type 2 diabetic patients?. Kor Diabetes J 2010, 34:174-181.
50. Ozasa N., Furukawa Y., Morimoto T., Tadamura E., Kita T., Kimura T. Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes. Hypertens Res 2008, 31:425-432.
51. Miyazato J., Horio T., Takishita S., Kawano Y. Fasting plasma glucose is an independent determinant of left ventricular diastolic dysfunction in nondiabetic patients with treated essential hypertension. Hypertens Res 2002, 25:403-409.
52. Lieb W., Xanthakis V., Sullivan L.M., Aragam J., Pencina M.J., Larson M.G., et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation 2009, 119:3085-3092.
53. Kuch B., von Scheidt W., Peter W., Doring A., Piehlmeier W., Landgraf R., et al. Sex-specific determinants of left ventricular mass in pre-diabetic and type 2 diabetic subjects: the Augsburg Diabetes Family Study. Diabetes Care 2007, 30:946-952.
54. Cefalu W.T. Translating "Nondiabetic" A1C levels to clinical practice: the art of medicine. Diabetes 2010, 59:1868-1869.
55. Tzoulaki I., Siontis K.C., Ioannidis J.P. Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study. BMJ (Clin Res Ed) 2011, 343:d6829.
56. Tahara Y., Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995, 18:440-447.